Sign in to view content

Pegcetacoplan vs Avacincaptad Pegol in Geographic Atrophy: Anchored Matching-Adjusted Indirect Comparisons of Three Phase 3 Trials Over 24 Months

Paul Hahn, MD, PhD, FASRS

Video
Published 2024

Related

Characterizing Real-World Functional Outcomes in Patients with Geographic Atrophy: An IRIS Registry Analysis
Durga Borkar, MD
Annual Meeting Talks
2022
Therapeutic Horizons for Dry AMD
Robert L. Avery, MD
Updates from the Field
2019
Safety of Intravitreal Pegcetacoplan for Geographic Atrophy: 12-Month Results of the OAKS and DERBY Trials
Caroline Baumal, MD
Annual Meeting Talks
2022

Category: AMD-Non-Neovascular

See more